041960.KQ Komipharm International Co., Ltd.
KOEHealthcareAs of 2026-08-20 11:54
Why 041960.KQ matters now
Komipharm International Co., Ltd. (041960.KQ) is a Korea stock in Healthcare. The latest InvestLog snapshot shows ₩9,650.00 with +3.76% on the session and ₩713.00B in market capitalization.
Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E -270.11, gross margin 33.3%, and operating margin 1.9%.
Valuation
P/E (TTM)
-270.11
PEG
—
P/B
9.68
P/S
13.11
EV/EBITDA
175.20
DCF Value
—
FCF Yield
-0.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
33.3%
Operating Margin
1.9%
Net Margin
-4.9%
ROE
-3.6%
ROA
-1.9%
ROIC
0.8%
Listing Info
Market
Korea
Exchange
KOE
Currency
KRW
Sector
Healthcare
Industry
Biotechnology
Country
KR
Komipharm International Co., Ltd. is a South Korean biopharmaceutical firm specializing in the research, development, and production of veterinary pharmaceuticals and animal vaccines. Their extensive portfolio features vaccines designed for livestock like swine, cattle, and poultry, as well as companion animals such as canines. Complementing these, they offer antibiotics, disinfectants, and bio-fertilizers, in addition to providing clinical laboratory services. The company is also expanding its focus to human health, with ongoing development of anticancer drugs and pain management agents.